Astera Labs, Inc. (ALAB) FY2025 Q1 Statement of Cash Flows

Statement of Cash Flows

2025-01-01 to 2025-03-31

Swipe to see the full flow
Astera Labs, Inc. cash flow reconciliation, Jan 1, 2025 through Mar 31, 2025One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income (loss) → Net cash from operating activities: $10,504,000.00Net income (loss) → Operating adjustments reconciliation: $21,315,000.00Stock-based compensation → Operating adjustments reconciliation: $42,446,000.00Accounts payable → Operating adjustments reconciliation: $2,226,000.00Depreciation and amortization → Operating adjustments reconciliation: $1,125,000.00Non-cash operating lease expense → Operating adjustments reconciliation: $696,000.00Warrants contra revenue → Operating adjustments reconciliation: $374,000.00Operating adjustments reconciliation → Accounts receivable, net: $30,968,000.00Operating adjustments reconciliation → Prepaid expenses and other assets: $14,495,000.00Operating adjustments reconciliation → Accrued expenses and other liabilities: $11,676,000.00Operating adjustments reconciliation → Inventory: $6,787,000.00Operating adjustments reconciliation → Accretion of discounts on marketable securities: $2,542,000.00Operating adjustments reconciliation → Other, net: $1,025,000.00Operating adjustments reconciliation → Operating lease liability: $689,000.00Proceeds from exercises of stock options, net of repurchases → financing reconciliation: $386,000.00financing reconciliation → Net cash from financing activities: $386,000.00Net cash used in investing activities → investing reconciliation: $3,940,000.00Sales and maturities of marketable securities → investing reconciliation: $191,420,000.00investing reconciliation → Purchases of marketable securities: $190,821,000.00investing reconciliation → Purchases of property and equipment: $4,539,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $80,044,000.00Net cash from operating activities → Cash sources and uses: $10,504,000.00Net cash from financing activities → Cash sources and uses: $386,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $86,994,000.00Cash sources and uses → Net cash used in investing activities: $3,940,000.00Warrants contra revenue: $374,000.00Warrants contra revenue+$374.00 KAccretion of discounts on marketable securities: -$2,542,000.00Investment discount & premium−$2.54 MAccounts receivable, net: -$30,968,000.00Accounts receivable−$30.97 MDepreciation and amortization: $1,125,000.00Depreciation & amortization+$1.13 MStock-based compensation: $42,446,000.00Stock-based compensation+$42.45 MPrepaid expenses and other assets: -$14,495,000.00Prepaid & other assets−$14.50 MAccounts payable: $2,226,000.00Accounts payable+$2.23 MNon-cash operating lease expense: $696,000.00Operating lease amortization+$696.00 KInventory: -$6,787,000.00Inventories−$6.79 MNet income (loss): $31,819,000.00Net income (loss)+$31.82 MAccrued expenses and other liabilities: -$11,676,000.00Accrued & other liabilities−$11.68 MOperating lease liability: -$689,000.00Operating lease liabilities−$689.00 KOther, net: -$1,025,000.00Other non-cash items−$1.03 MNet cash from operating activities: $10,504,000.00Operating cash+$10.50 MOperating adjustments reconciliation: $68,182,000.00Tax withholding related to net share settlements of restricted stock units: $0.00Payment of deferred offering costs: $0.00Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions: $0.00Proceeds from exercises of stock options, net of repurchases: $386,000.00Stock option exercises+$386.00 KNet cash from financing activities: $386,000.00Financing cash+$386.00 Kfinancing reconciliation: $386,000.00Purchases of marketable securities: -$190,821,000.00AFS securities purchases−$190.82 MPurchases of property and equipment: -$4,539,000.00PP&E purchases−$4.54 MSales and maturities of marketable securities: $191,420,000.00Marketable securities proceeds+$191.42 MNet cash used in investing activities: -$3,940,000.00. Cash required to fund net payments.Investing cash−$3.94 Minvesting reconciliation: $195,360,000.00Cash sources and uses: $90,934,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $80,044,000.00Beginning cash$80.04 MEnding cash: Cash, cash equivalents, and restricted cash: $86,994,000.00Ending cash$86.99 MCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsFree cash flow$5.97 MOperating cash − cash spent on PP&ECash flow / Net income0.33×Operating cash flow ÷ net incomeNet cash change+$6.95 MEnding cash − beginning cash
Chart details

Astera Labs, Inc. cash flow reconciliation, Jan 1, 2025 through Mar 31, 2025

Cash flows for Jan 1, 2025 through Mar 31, 2025. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2024. Ending cash: Mar 31, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2024
80,044,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
10,504,000 US dollars. Net cash provided.
Net income (loss)
31,819,000 US dollars
Warrants contra revenue
374,000 US dollars
Accretion of discounts on marketable securities
negative 2,542,000 US dollars
Accounts receivable, net
negative 30,968,000 US dollars
Depreciation and amortization
1,125,000 US dollars
Stock-based compensation
42,446,000 US dollars
Prepaid expenses and other assets
negative 14,495,000 US dollars
Accounts payable
2,226,000 US dollars
Non-cash operating lease expense
696,000 US dollars
Inventory
negative 6,787,000 US dollars
Accrued expenses and other liabilities
negative 11,676,000 US dollars
Operating lease liability
negative 689,000 US dollars
Other, net
negative 1,025,000 US dollars
Investing activities
negative 3,940,000 US dollars. Net cash used.
Purchases of marketable securities
negative 190,821,000 US dollars
Purchases of property and equipment
negative 4,539,000 US dollars
Sales and maturities of marketable securities
191,420,000 US dollars
Financing activities
386,000 US dollars. Net cash provided.
Tax withholding related to net share settlements of restricted stock units
0 US dollars
Payment of deferred offering costs
0 US dollars
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions
0 US dollars
Proceeds from exercises of stock options, net of repurchases
386,000 US dollars
Operating adjustment reconciliation
68,182,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
386,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
195,360,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Mar 31, 2025
86,994,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
90,934,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
6,950,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.33×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
10,504,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
4,539,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
5,965,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $10.50M of net income directly to operating cash and $21.32M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 10,504,000 US dollars minus 4,539,000 US dollars equals 5,965,000 US dollars.
Astera Labs, Inc. (ALAB) FY2025 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!